播恩集团股份有限公司 董事会提名委员会工作制度 第一章 总则 第一条 为规范播恩集团股份有限公司（以下简称"公司"）董事和高级管理人员的提名， 优化董事会组成，完善公司治理结构，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司治理准则》、《播恩集团股份有限公司章程》（以下简称"公司章程"）及其他有关规定， 公司特设立董事会提名委员会，并制定本工作制度。 提名委员会召集人负责召集和主持提名委员会会议，当提名委员会召集人不能或无法履行职 责时，由其指定一名其他委员代行其职责；提名委员会召集人既不履行职责，也不指定其他委员 代行其职责时，任何一名委员均可将有关情况向公司董事会报告，由公司董事会指定一名委员履 行提名委员会召集人职责。 第六条 提名委员会委员任期与同届董事会董事的任期相同，委员任期届满，连选可以连任。 提名委员会委员任期届满前，除非出现《公司法》、公司章程或本工作制度规定的不得任职的情 形，不得被无故解除职务。 期间如有委员不再担任公司董事职务，自动失去委员资格，并由董事会根据公司章程及本工 作制度规定补足委员人数。 第二条 董事会提名委员会是董事会按照股东大会决议设立的专门工作机 ...

播恩集团股份有限公司 章 程 1 播恩集团股份有限公司 章程 第一章 总则 第一条 为维护播恩集团股份有限公司（以下简称"公司"）、股东和债权人的合 法权益，规范公司的组织和行为，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司章程指引》《上市公司 治理准则》《深圳证券交易所股票上市规则》和其他有关规定，制订本章程。 第二条 公司系依照《公司法》和其他有关法律、法规成立的股份有限公司。 公司采取发起设立的方式设立；在赣州市市场监督管理局注册登记，取得营业执照， 统一社会信用代码为 91360700787285803X。 第三条 公司于 2023 年 2 月 7 日经中国证券监督管理委员会（以下简称"中国 证监会"）批准，首次向社会公众发行人民币普通股 4,035 万股，并于 2023 年 3 月 7 日 在深圳证券交易所上市。 第四条 公司注册名称： 中文全称：播恩集团股份有限公司 第五条 公司住所：江西省赣州经济技术开发区迎宾大道中段。 第六条 公司注册资本为人民币 16,068 万元。 第七条 公司为永久存续的股份有限公司。 第八条 ...

独立董事意见 播恩集团股份有限公司独立董事 关于第三届董事会第五次会议相关事项的独立意见 根据《公司法》、播恩集团股份有限公司（以下简称"公司"）的《独立董 事工作制度》、《公司章程》等文件规定，作为公司的独立董事，本着认真、负 责的态度，基于独立、审慎、客观的立场，我们对公司第三届董事会第五次会议 审议的相关事项进行了认真审核，并发表如下独立意见： 3、我们一致同意聘任曹思颖女士为公司董事会秘书。 （以下无正文） 独立董事意见 （本页无正文，为播恩集团股份有限公司独立董事关于第三届董事会第五次会议 相关事项的独立意见之签署页） 李德发 瞿明仁 曹丽梅 一、关于公司聘任董事会秘书的独立意见 1、公司本次聘任董事会秘书的提名、聘任和表决程序符合《公司法》以及 《公司章程》的相关规定，程序合法、有效。 2、经审阅公司本次聘任的董事会秘书的个人履历及相关资料，上述人员符 合《公司法》《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律 监管指引第 1 号——主板上市公司规范运作》以及《公司章程》所规定的任职条 件。 2023 年 11 月 20 日 ...

证券代码：001366 证券简称：播恩集团 公告编号：2023-055 播恩集团股份有限公司 关于审计机构变更项目质量控制复核人的公告 一、变更情况 中汇原委派许菊萍女士为质量控制复核人，根据最新工作安排调整，现变更 朱敏女士作为公司 2023 年度财务报告及内部控制审计的项目质量控制复核人， 继续完成相关工作。 二、变更后的项目质量控制复核人基本信息、诚信记录及独立性情况 1、基本信息 1 项目质量控制复核人朱敏女士，1995 年成为中国注册会计师，1993 年起开 始从事上市公司审计工作，2011 年起开始在中汇执业，2023 年开始为公司提供 审计服务，近三年签署及复核过 10 家以上的上市公司审计报告，具备相应专业 胜任能力。 2、诚信记录 朱敏女士近三年均不存在因执业行为受到刑事处罚，或受到证监会及其派出 机构、行业主管部门的行政处罚、监督管理措施，或受到证券交易场所、行业协 会等自律组织的自律监管措施、纪律处分的情况。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 播恩集团股份有限公司（以下简称"公司"）于 2023 年 4 月 11 日召开第二 ...

证券代码：001366 证券简称：播恩集团 公告编号：2023-054 播恩集团股份有限公司 第三届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、会议通知的时间和方式：本次会议通知于 2023 年 11 月 15 日以电子邮件 方式发出。 2、会议的时间、地点和方式：本次会议于 2023 年 11 月 20 日在播恩集团股 份有限公司（以下简称"公司"）广州分公司会议室以现场结合通讯的方式召开。 3、会议出席情况：本次会议应出席董事 7 名，实际出席董事 7 名，公司监 事、高级管理人员及本次拟聘董事会秘书列席会议。 4、本次会议由董事长邹新华先生主持。 5、本次会议的召开符合《公司法》和《公司章程》及相关法律、法规的规 定，会议决议合法、有效。 二、董事会会议审议情况 1、会议以 7 票同意、0 票反对、0 票弃权的结果，审议通过《关于聘任公 司董事会秘书的议案》。 根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管 指引第 1 号——主板上市公司规范运作》及《公司章程》等相关规定，经董 ...

Financial Performance - The company's revenue for Q3 2023 was CNY 353,408,886.94, a decrease of 28.49% compared to the same period last year[5]. - Net profit attributable to shareholders was CNY 9,197,440.82, down 71.55% year-on-year[5]. - The net profit after deducting non-recurring gains and losses was CNY 5,108,054.95, a decline of 77.88% compared to the previous year[5]. - Total operating revenue for the period was CNY 1,107,353,129.49, a decrease of 7.03% compared to CNY 1,191,187,904.58 in the previous period[19]. - Net profit for the period was CNY 34,125,836.71, a decline of 31.6% from CNY 49,778,739.59 in the previous period[20]. - Earnings per share for the period were CNY 0.22, down from CNY 0.41 in the previous period[20]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,019,203,425.17, an increase of 37.99% from the end of the previous year[5]. - As of September 30, 2023, the total assets of the company reached CNY 1,019,203,425.17, an increase from CNY 738,593,191.57 at the beginning of the year, representing a growth of approximately 38.1%[16]. - The company's equity attributable to shareholders rose by 62.19% to CNY 845,710,214.89 compared to the end of the previous year[5]. - Total current liabilities decreased to CNY 94,108,565.77 from CNY 137,859,594.87, a reduction of approximately 31.7%[17]. - The company’s total liabilities decreased to CNY 173,493,210.28 from CNY 217,169,422.58, a decline of about 20.1%[17]. Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY 10,594,085.91, a decrease of 277.99% year-on-year[5]. - The company reported a net cash outflow from operating activities of CNY -10,594,085.91, compared to a net inflow of CNY 5,952,088.35 in the previous period[21]. - Cash and cash equivalents at the end of the period totaled CNY 342,303,631.35, an increase from CNY 128,694,110.45 at the end of the previous period[22]. - The company's cash and cash equivalents amounted to CNY 343,946,631.35, up from CNY 150,755,832.56 at the start of the year, indicating a significant increase of about 128.5%[16]. Research and Development - Research and development expenses increased by 30.95% compared to the same period last year, indicating a focus on innovation[10]. - Research and development expenses increased to CNY 21,854,558.55, up 30.9% from CNY 16,688,604.59 in the previous period[19]. Financing Activities - The company reported a 238.24% increase in net cash flow from financing activities, primarily due to funds raised from the initial public offering[10]. - The company raised CNY 344,262,000.00 from financing activities, significantly higher than CNY 86,159,215.40 in the previous period[22]. Other Financial Metrics - The company experienced a significant increase in other income, which rose by 410.19% year-on-year, due to the recognition of previously payable accounts[10]. - Accounts receivable increased by 160.94% compared to the end of the previous year, reflecting an increase in customer credit to expand market reach[9]. - Accounts receivable increased to CNY 52,816,732.50 from CNY 20,240,811.70, reflecting a growth of approximately 161.5%[16]. - Inventory decreased to CNY 160,572,446.49 from CNY 169,844,405.69, showing a decline of about 5.5%[16]. - The company reported a total non-current asset value of CNY 422,303,695.63, up from CNY 370,080,356.40, indicating an increase of approximately 14.1%[17]. - The company’s capital reserve increased significantly to CNY 373,363,633.43 from CNY 94,658,597.14, reflecting a growth of approximately 294.5%[17]. - The company's equity increased to CNY 573,710,214.89 from CNY 421,423,769.99, representing a growth of about 36.1%[17]. Accounting and Reporting - The company implemented a new accounting standard starting January 1, 2023, which had no significant impact on the financial statements[23]. - The third quarter report was not audited[24].

证券代码：001366 证券简称：播恩集团 公告编号：2023-052 播恩集团股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 播恩集团股份有限公司（以下简称"公司"）股票（证券简称：播恩集团， 证券代码：001366）连续二个交易日收盘价涨幅偏离值累计超过 20%（2023 年 8 月 25 日、2023 年 8 月 28 日），根据《深圳证券交易所交易规则》的有关规定， 属于股票交易异常波动的情况。 4、公司控股股东和实际控制人在公司股票交易异常波动期间未买卖公司股 票。 5、公司、控股股东、实际控制人不存在关于公司的应披露而未披露的重大 事项，也不存在处于筹划阶段的重大事项。 6、公司不存在违反公平信息披露规定的情形。 三、是否存在应披露而未披露信息的说明 公司董事会确认，公司目前没有任何根据《深圳证券交易所股票上市规则》 等有关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、协 议等；董事会也未获悉公司有根据《深圳证券交易所股票上市规则》等有关规定 应予以披露而未披露的、 ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥753,944,242.55, representing an increase of 8.17% compared to ¥696,995,573.83 in the same period last year[22]. - The net profit attributable to shareholders of the listed company reached ¥24,928,395.89, a significant increase of 42.89% from ¥17,445,635.29 in the previous year[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥19,784,913.17, up 27.59% from ¥15,507,092.29 in the same period last year[22]. - The basic earnings per share increased by 21.43% to ¥0.17 from ¥0.14 in the previous year[22]. - The total operating revenue for the first half of 2023 reached CNY 753,944,242.55, an increase from CNY 696,995,573.83 in the same period of 2022, reflecting a growth of approximately 8.2%[147]. - The total profit for the first half of 2023 was CNY 28,009,626.80, compared to CNY 18,782,568.07 in the same period of 2022, marking a growth of 49.0%[149]. - The company reported a financial expense of CNY -2,622,632.84, which is an increase in income compared to CNY -686,226.82 in the previous year[151]. - The tax expense for the first half of 2023 was CNY 3,081,230.91, significantly higher than CNY 1,336,932.78 in the same period of 2022, indicating a rise of 130.2%[149]. Assets and Liabilities - The total assets at the end of the reporting period were ¥997,514,048.76, reflecting a growth of 35.06% compared to ¥738,593,191.57 at the end of the previous year[22]. - The total liabilities decreased to CNY 161,001,274.69 from CNY 217,169,422.58, showing a reduction of about 26%[141]. - The equity attributable to shareholders increased significantly to CNY 836,512,774.07 from CNY 521,423,768.99, marking an increase of approximately 60.4%[141]. - The company’s total assets included cash and cash equivalents accounting for 37.96% of total assets, up from 20.41% at the end of the previous year[49]. - The total cash and cash equivalents at the end of the period amounted to CNY 375,493,045.34, up from CNY 112,679,806.38 at the end of the first half of 2022[155]. - The total liabilities at the end of the current period are 216,461 million, which represents a slight increase compared to the previous period[165]. Cash Flow - The net cash flow from operating activities improved to -¥15,870,688.81, a 24.43% improvement from -¥21,000,773.51 in the same period last year[22]. - The total cash inflow from operating activities for the first half of 2023 was CNY 738,605,042.23, an increase of 13.6% compared to CNY 649,913,258.13 in the same period of 2022[154]. - The cash inflow from financing activities reached CNY 344,262,000.00, significantly higher than CNY 71,529,080.40 in the previous year, marking a 382.5% increase[155]. - The cash outflow from investment activities was CNY 42,599,166.66, a decrease of 33.9% from CNY 64,477,917.73 in the same period last year[155]. Research and Development - The company has established a strong technical service platform, developing unique technologies such as OEN efficient nutrition and dual-acid clean breeding model[31]. - The company holds 72 invention patents and 27 utility model patents, showcasing its technological advantages in feed formulation and processing[36]. - Research and development expenses rose by 39.96% to CNY 15.15 million, reflecting the company's commitment to enhancing product innovation and technology[44]. - The company has established multiple research and development platforms, enhancing its technological capabilities and innovation in the feed industry[39]. Market and Sales - The company achieved feed sales of 160,240 tons, a year-on-year increase of 10.04%, with operating revenue of CNY 753.94 million, up 8.17% year-on-year, and a net profit attributable to shareholders of CNY 24.93 million, reflecting a growth of 42.89%[42]. - The sales revenue from pig feed reached CNY 728.32 million, an increase of 5.30% year-on-year, while poultry feed sales surged to 3,613.75 tons, up 1,116.96%, generating revenue of CNY 15.14 million, a growth of 838.53%[42]. - The company has expanded its market presence across multiple provinces and cities in China, becoming a national feed supplier[31]. - The company is focusing on enhancing its technological capabilities to improve operational efficiency and customer satisfaction[164]. Risks and Challenges - The company faced risks related to the cyclical fluctuations in the pig farming industry, which could impact overall performance if pig prices remain low[66]. - The company is exposed to risks from price fluctuations of key raw materials, which could adversely affect procurement costs and profitability[67]. - The company is vulnerable to risks from diseases in the pig farming industry, which could reduce feed demand and negatively impact performance[70]. - The company faces risks from potential adjustments to prohibited farming areas, which could impact short-term operations if new customers are not acquired[71]. Corporate Governance and Compliance - The company emphasizes the protection of shareholder rights, particularly for minority shareholders, ensuring their decision-making, information, and profit rights are safeguarded[87]. - The company adheres to labor laws and regulations, ensuring employee rights and providing training programs for staff development[88]. - The company has established a safety production management system to enhance employee safety awareness and risk control[89]. - The company did not engage in any major related party transactions during the reporting period[102]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[149]. - Future guidance indicates a projected revenue growth of approximately 10% for the next fiscal year, driven by new market strategies and product launches[164]. - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its product offerings[161].

证券代码：001366 证券简称：播恩集团 公告编号：2023-051 播恩集团股份有限公司 2023年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 播恩集团股份有限公司（以下简称"公司"）根据中国证券监督管理委员会《上 市公司监管指引第2号——上市公司募集资金管理和使用的监管要求》《深圳证券交 易所上市公司自律监管指引第1号——主板上市公司规范运作》等相关规定，将公司 2023年半年度募集资金存放与使用情况作专项报告如下： 一、募集资金基本情况 1、实际募集资金金额、资金到位情况 经中国证券监督管理委员会《关于核准播恩集团股份有限公司首次公开发行股票 的批复》（证监许可[2023]271号）核准，公司首次公开发行人民币普通股（A股）股 票4,035万股，每股面值1元，每股发行价格为人民币9.32元,募集资金总额为人民币 37,606.20万元，扣除海通证券股份有限公司保荐与承销费用合计3,180.00万元，实 际收到34,426.20万元募集资金，此外公司累计发生2,520.70万元的其他相关发行费 用（信息披露、律 ...

证券代码：001366 证券简称：播恩集团 公告编号：2023-047 播恩集团股份有限公司 第三届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、会议通知的时间和方式：本次会议通知于 2023 年 8 月 14 日以电子邮件 方式发出。 2、会议的时间、地点和方式：本次会议于 2023 年 8 月 24 日在播恩集团股 份有限公司（以下简称"公司"）广州分公司会议室以现场结合通讯的方式召开。 3、会议出席情况：本次会议应出席董事 7 名，实际出席董事 7 名，公司监 事、高级管理人员列席会议。 4、本次会议由董事长邹新华先生主持。 5、本次会议的召开符合《公司法》和《公司章程》及相关法律、法规的规 定，会议决议合法、有效。 经审议，与会董事认为：公司《2023 年半年度报告》及其摘要的编制和审 核程序相关法律、法规和中国证券监督管理委员会规范性文件的规定，报告内容 1 公允地反映了公司的经营状况和经营成果，所披露的信息真实、准确、完整，不 存在虚假记载、误导性陈述或重大遗漏。 《2023 年半年度报告》详 ...